Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30, Biphasic Insulin Aspart 50/50, and Biphasic Insulin Aspart 30/70 All in Combination With Metformin in Subjects With Type 2 Diabetes (the INTENSIMIX Trial).
Latest Information Update: 23 Dec 2021
At a glance
- Drugs Insulin aspart/insulin protamine aspart (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms INTENSIMIX
- Sponsors Novo Nordisk
- 09 Nov 2012 Planned number of patients changed from 600 to 750 as reported by European Clinical Trials Database.
- 20 May 2009 Patient number changed from 600 to 603 as reported by ClinicalTrials.gov.
- 31 Oct 2005 New trial record.